Full-Time

Clinical Lab Associate

Returns, Monday-Friday, 4:00pm-12:30am

Confirmed live in the last 24 hours

Tempus

Tempus

1,001-5,000 employees

AI-driven healthcare data analysis platform

AI & Machine Learning
Biotechnology
Healthcare

Entry, Junior

Chicago, IL, USA

Category
Diagnostics & Laboratory Professionals
Medical, Clinical & Veterinary
Requirements
  • High School degree or GED required.
  • Bachelor's Degree in a related field preferred.
  • Highly organized and systematic, superb attention to detail and ability to complete tasks with a high degree of accuracy.
  • Show initiative and ability to work as part of a high-level team while working independently on mission-critical tasks.
  • Proven ability to learn new skills quickly and adapt to new processes smoothly.
  • Computer proficiency with equivalent knowledge of standard software and general familiarity of standard office equipment and technology.
Responsibilities
  • Facilitate efficient specimen return and send-outs to custodian pathology laboratories and Tempus partners
  • Monitor high-priority requests and audits to ensure customer retention and satisfaction
  • Sort, file, and maintain long-term FFPE specimen storage
  • Develop a firm understanding of lab processes and databases
  • Ensure all sample return documentation is professional, accurate, and HIPAA-compliant
  • Engage in timely issue reporting and resolution
  • Build and maintain effective relationships with other laboratory employees

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in the healthcare sector. The company offers a platform that analyzes medical data, helping physicians make better treatment decisions by providing insights from medical images and identifying care gaps. For pharmaceutical and biotech companies, Tempus aids in drug development by discovering new targets and assessing treatment effectiveness. Patients benefit from personalized therapy options identified through the platform. Tempus conducts significant research, particularly in cancer, and has developed tools like a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. The company generates revenue by charging healthcare providers and companies for access to its platform and insights.

Company Stage

IPO

Total Funding

$894.9M

Headquarters

Chicago, Illinois

Founded

2015

Growth & Insights
Headcount

6 month growth

5%

1 year growth

15%

2 year growth

36%
Simplify Jobs

Simplify's Take

What believers are saying

  • Tempus's IPO and significant revenue generation indicate strong financial health and growth potential.
  • Collaborations with industry giants like SoftBank and United Therapeutics can lead to groundbreaking advancements and increased market share.
  • The company's focus on personalized therapy and AI-driven insights can significantly improve patient outcomes, making it a rewarding place to work for those passionate about healthcare innovation.

What critics are saying

  • The lawsuit from Guardant Health over patent infringement could result in financial and reputational damage.
  • Operating in a highly competitive market with peers like Foundation Medicine and Guardant Health requires continuous innovation to maintain a competitive edge.

What makes Tempus unique

  • Tempus leverages AI to provide actionable insights from medical data, setting it apart from competitors who may not integrate AI as deeply into their platforms.
  • Their focus on personalized therapy options and extensive cancer research, including a pan-cancer organoid platform and liquid biopsy assay, distinguishes them in the healthcare tech space.
  • Tempus's collaboration with major firms like SoftBank and United Therapeutics highlights its strong industry partnerships and credibility.

Help us improve and share your feedback! Did you find this helpful?